newsfilter
← Latest News
GlobeNewswire·

LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

  • Kirby McInerney LLP is investigating potential federal securities law violations & unlawful business practices by Liquidia Corporation (NASDAQ: LQDA) & its senior management.
  • On September 30, 2026, the U.S. District Court for the District of Delaware ruled that Liquidia's Yutrepia inhalation powder infringed claims 1 & 14 of United Therapeutics Corporation's '327 patent.
  • Liquidia CEO Roger Jeffs stated the company disagrees with the ruling & plans to pursue all available appellate options.
  • Following the court decision, Liquidia shares declined by 57.2% from $70.69 on September 29, 2026, to close at $30.26 on September 30, 2026.
  • No lawsuit has been filed yet as the investigation remains ongoing to determine if claims can be brought under federal securities laws.
  • Investors who acquired Liquidia securities may contact Lauren Molinaro at investigations@kmllp.com to learn more about their rights at no cost.